SCHEMBL4825137

SCHEMBL4825137

CCc1cccc(CC)c1-c1cc(OCCN2CCOCC2)c(COc2cc(OC)ccc2C(C)=O)c(C)n1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTPN1 P18031 1/20 0.43
LMNA P02545 2/20 0.42
HTR2A P28223 1/20 0.41
KCNH2 Q12809 1/20 0.41
HRH3 Q9Y5N1 1/20 0.41
KDR P35968 3/20 0.40
LCK P06239 1/20 0.40
SRC P12931 1/20 0.40
MAPK14 Q16539 1/20 0.40
MAPK1 P28482 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
USP2 O75604 1/20 0.40
GLA P06280 1/20 0.40
TSHR P16473 1/20 0.40
CASP1 P29466 1/20 0.40
CASP7 P55210 1/20 0.40
CNR1 P21554 2/20 0.40
CNR2 P34972 2/20 0.40
CD274 Q9NZQ7 1/20 0.40
KDM4E B2RXH2 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4824163 0.81 AKR1C3 (0.43) MAPK1L3MBTL1ALDH1A1AKR1C3POLB
SCHEMBL1328014 0.80 HTR1A (0.39) CD274POLB
SCHEMBL2139611 0.79 SMN1; SMN2 (0.49) LMNAL3MBTL1ALDH1A1POLB
SCHEMBL1327139 0.76 AKR1C3 (0.39) L3MBTL1AKR1C3POLB
SCHEMBL1327978 0.74 PRMT5 (0.43) POLB
SCHEMBL2140956 0.73 ALDH1A1 (0.43) LMNAHRH3CD274KDM4EALDH1A1
SCHEMBL4824976 0.72 AKR1C3 (0.41) LMNAL3MBTL1ALDH1A1AKR1C3
SCHEMBL1327910 0.71 SCN9A (0.43) LMNAKCNH2MAPK1CASP1CASP7
SCHEMBL1327671 0.70 C5AR1 (0.46) LMNAKDM4EALDH1A1
SCHEMBL1329649 0.70 PTGS1 (0.40) LMNAMAPK14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7342115-B2 Binding antagonist and arylpyridine for antiinflammatory agents, cardiovascular disorders and antagonist or agonist and for immunology NEUROGEN CORPORATION (US) 2008-03-11 US disclosed